M. Corr, A. Slanetz, L. Boyd, M. Jelonek, S. Khilko et al., T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity, Science, vol.265, issue.5174, pp.946-949, 1994.
DOI : 10.1126/science.8052850

K. Matsui, J. Boniface, P. Steffner, P. Reay, and M. Davis, Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness., Proceedings of the National Academy of Sciences, vol.91, issue.26, pp.12862-12866, 1994.
DOI : 10.1073/pnas.91.26.12862

K. Garcia, M. Tallquist, L. Pease, A. Brunmark, C. Scott et al., ???? T cell receptor interactions with syngeneic and allogeneic ligands: Affinity measurements and crystallization, Proceedings of the National Academy of Sciences, vol.90, issue.23, pp.13838-13843, 1997.
DOI : 10.1073/pnas.90.23.11272

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC28394

C. Liu, D. Parker, J. Kappler, and P. Marrack, Selection of Antigen-specific T Cells by a Single IEk Peptide Combination, Journal of Experimental Medicine, vol.355, issue.6357, pp.1441-1450, 1997.
DOI : 10.1038/355224a0

D. Garboczi, U. Utz, P. Ghosh, A. Seth, J. Kim et al., Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2, J Immunol, vol.157, pp.5403-5410, 1996.

J. Altman, P. Moss, P. Goulder, D. Barouch, M. Mcheyzer-williams et al., Phenotypic Analysis of Antigen-Specific T Lymphocytes, Science, vol.336, issue.6198, pp.94-96, 1996.
DOI : 10.1084/jem.183.4.1367

P. Dunbar and G. Ogg, Oligomeric MHC molecules and their homologues: state of the art, Journal of Immunological Methods, vol.268, issue.1, pp.3-7, 2002.
DOI : 10.1016/S0022-1759(02)00194-1

V. Appay and R. Sl, The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining, Journal of Immunological Methods, vol.268, issue.1, pp.9-19, 2002.
DOI : 10.1016/S0022-1759(02)00195-3

M. Callan, L. Tan, N. Annels, G. Ogg, J. Wilson et al., T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo, The Journal of Experimental Medicine, vol.150, issue.9, pp.1395-1402, 1998.
DOI : 10.1084/jem.186.9.1407

G. Gillespie, M. Wills, V. Appay, O. Callaghan, C. Murphy et al., Functional Heterogeneity and High Frequencies of Cytomegalovirus-Specific CD8+ T Lymphocytes in Healthy Seropositive Donors, Journal of Virology, vol.74, issue.17, pp.8140-8150, 2000.
DOI : 10.1128/JVI.74.17.8140-8150.2000

S. Migueles, M. Sabbaghian, W. Shupert, M. Bettinotti, F. Marincola et al., HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors, Proceedings of the National Academy of Sciences, vol.375, issue.6532, pp.2709-2714, 2000.
DOI : 10.1038/375606a0

L. Tan, N. Gudgeon, N. Annels, P. Hansasuta, O. Callaghan et al., A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers, J Immunol, vol.162, pp.1827-1835, 1999.

P. Romero, P. Dunbar, D. Valmori, M. Pittet, G. Ogg et al., Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes, The Journal of Experimental Medicine, vol.57, issue.9, pp.1641-1650, 1998.
DOI : 10.1126/science.274.5291.1363

D. Garboczi, D. Hung, and D. Wiley, HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides., Proceedings of the National Academy of Sciences, vol.89, issue.8, pp.3429-3433, 1992.
DOI : 10.1073/pnas.89.8.3429

C. Hackett and O. Sharma, Frontiers in peptide???MHC class II multimer technology, Nature Immunology, vol.3, issue.10, pp.887-889, 2002.
DOI : 10.1038/ni1002-887

R. Latek, S. Petzold, and E. Unanue, Hindering auxiliary anchors are potent modulators of peptide binding and selection by I-Ak class II molecules, Proceedings of the National Academy of Sciences, vol.257, issue.5072, pp.11460-11465, 2000.
DOI : 10.1126/science.1323877

T. Cameron, P. Norris, A. Patel, C. Moulon, E. Rosenberg et al., Labeling antigen-specific CD4+ T cells with class II MHC oligomers, Journal of Immunological Methods, vol.268, issue.1, pp.51-69, 2002.
DOI : 10.1016/S0022-1759(02)00200-4

P. Savage, J. Boniface, and M. Davis, A Kinetic Basis For T Cell Receptor Repertoire Selection during an Immune Response, Immunity, vol.10, issue.4, pp.485-492, 1999.
DOI : 10.1016/S1074-7613(00)80048-5

I. Gutgemann, A. Fahrer, J. Altman, M. Davis, and Y. Chien, Induction of Rapid T Cell Activation and Tolerance by Systemic Presentation of an Orally Administered Antigen, Immunity, vol.8, issue.6, pp.667-673, 1998.
DOI : 10.1016/S1074-7613(00)80571-3

F. Crawford, H. Kozono, J. White, P. Marrack, and J. Kappler, Detection of Antigen-Specific T Cells with Multivalent Soluble Class II MHC Covalent Peptide Complexes, Immunity, vol.8, issue.6, pp.675-682, 1998.
DOI : 10.1016/S1074-7613(00)80572-5

L. Malherbe, C. Filippi, J. V. Foucras, G. Moro, M. Appel et al., Selective Activation and Expansion of High-Affinity CD4+ T Cells in Resistant Mice upon Infection with Leishmania major, Immunity, vol.13, issue.6, pp.771-782, 2000.
DOI : 10.1016/S1074-7613(00)00075-3

H. Appel, L. Gauthier, J. Pyrdol, and K. Wucherpfennig, Kinetics of T-cell Receptor Binding by Bivalent HLA-DR{middle dot}Peptide Complexes That Activate Antigen-specific Human T-cells, Journal of Biological Chemistry, vol.275, issue.1, pp.312-321, 2000.
DOI : 10.1074/jbc.275.1.312

G. Nepom, J. Buckner, E. Novak, S. Reichstetter, H. Reijonen et al., HLA class II tetramers: Tools for direct analysis of antigen-specific CD4+ T cells, Arthritis & Rheumatism, vol.46, issue.1, pp.5-12, 2002.
DOI : 10.1002/1529-0131(200201)46:1<5::AID-ART10063>3.0.CO;2-S

E. Novak, A. Liu, G. Nepom, and W. Kwok, MHC class II tetramers identify peptide-specific human CD4+ T cells proliferating in response to influenza A antigen, Journal of Clinical Investigation, vol.104, issue.12, pp.63-70, 1999.
DOI : 10.1172/JCI8476

S. Reichstetter, R. Ettinger, A. Liu, J. Gebe, G. Nepom et al., Distinct T Cell Interactions with HLA Class II Tetramers Characterize a Spectrum of TCR Affinities in the Human Antigen-Specific T Cell Response, The Journal of Immunology, vol.165, issue.12, pp.6994-6998, 2000.
DOI : 10.4049/jimmunol.165.12.6994

N. Danke and W. Kwok, HLA Class II-Restricted CD4+ T Cell Responses Directed Against Influenza Viral Antigens Postinfluenza Vaccination, The Journal of Immunology, vol.171, issue.6, pp.3163-3169, 2003.
DOI : 10.4049/jimmunol.171.6.3163

M. Lebowitz, O. Herrin, S. Hamad, A. Fahmy, T. Marguet et al., Soluble, High-Affinity Dimers of T-Cell Receptors and Class II Major Histocompatibility Complexes: Biochemical Probes for Analysis and Modulation of Immune Responses, Cellular Immunology, vol.192, issue.2, pp.175-184, 1999.
DOI : 10.1006/cimm.1999.1441

P. Arnold, K. Vignali, T. Miller, L. Gruta, N. Cauley et al., Reliable generation and use of MHC class II:??2aFc multimers for the identification of antigen-specific CD4+ T cells, Journal of Immunological Methods, vol.271, issue.1-2, pp.137-151, 2002.
DOI : 10.1016/S0022-1759(02)00343-5

P. Schatz, Use of Peptide Libraries to Map the Substrate Specificity of a Peptide-Modifying Enzyme: A 13 Residue Consensus Peptide Specifies Biotinylation in Escherichia coli, Bio/Technology, vol.74, issue.10, pp.1138-1143, 1993.
DOI : 10.1038/nbt1093-1138

J. Stockel, E. Meinl, C. Hahnel, J. Malotka, R. Seitz et al., Refolding of human class II major histocompatibility complex molecules isolated from Escherichia coli. Assembly of peptide-free heterodimers and increased refolding-yield in the presence of antigenic peptide, J Biol Chem, vol.269, pp.29571-29578, 1994.

S. Arimilli, C. Cardoso, P. Mukku, V. Baichwal, and B. Nag, Refolding and Reconstitution of Functionally Active Complexes of Human Leukocyte Antigen DR2 and Myelin Basic Protein Peptide from Recombinant and Polypeptide Chains, Journal of Biological Chemistry, vol.270, issue.2, pp.971-977, 1995.
DOI : 10.1074/jbc.270.2.971

P. Panina-bordignon, A. Tan, A. Termijtelen, S. Demotz, G. Corradin et al., Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells, European Journal of Immunology, vol.3, issue.12, pp.2237-2242, 1989.
DOI : 10.1002/eji.1830191209

S. Sadegh-nasseri and R. Germain, A role for peptide in determining MHC class II structure, Nature, vol.353, issue.6340, pp.167-170, 1991.
DOI : 10.1038/353167a0

T. Cameron, J. Cochran, B. Yassine-diab, R. Sekaly, and L. Stern, Cutting Edge: Detection of Antigen-Specific CD4+ T Cells by HLA-DR1 Oligomers Is Dependent on the T Cell Activation State, The Journal of Immunology, vol.166, issue.2, pp.741-745, 2001.
DOI : 10.4049/jimmunol.166.2.741

D. Eckels, T. Sell, S. Bronson, A. Johnson, R. Hartzman et al., Human helper T-cell clones that recognize different influenza hemagglutinin determinants are restricted by different HLA-D region epitopes, Immunogenetics, vol.271, issue.2, pp.409-423, 1984.
DOI : 10.1007/BF00364644

M. Lucas, C. Day, J. Wyer, S. Cunliffe, A. Loughry et al., Ex Vivo Phenotype and Frequency of Influenza Virus-Specific CD4 Memory T Cells, Journal of Virology, vol.78, issue.13, pp.7284-7287, 2004.
DOI : 10.1128/JVI.78.13.7284-7287.2004

G. Consogno, S. Manici, V. Facchinetti, A. Bachi, J. Hammer et al., Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3, Blood, vol.101, issue.3, pp.1038-1044, 2003.
DOI : 10.1182/blood-2002-03-0933

G. Harcourt, M. Lucas, I. Sheridan, E. Barnes, R. Phillips et al., Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes, Journal of Viral Hepatitis, vol.170, issue.4, pp.324-331, 2004.
DOI : 10.1084/jem.188.10.1785

M. Protti, A. Manfredi, C. Straub, X. Wu, J. Howard et al., Use of synthetic peptides to establish anti-human acetylcholine receptor CD4+ cell lines from myasthenia gravis patients, J Immunol, vol.144, pp.1711-1720, 1990.